Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
5
ProShares Ultra Energy
DIG
US Stock MarketDetailed Quotes
Prothena (PRTA)
- 9.400
- -0.420-4.28%
Trading Sep 8 09:32 ET
482.57MMarket Cap-11.46P/E (TTM)
9.630High9.400Low12.62KVolume9.600Open9.820Prev Close120.86KTurnover0.04%Turnover RatioLossP/E (Static)51.34MShares11.80052wk High1.68P/B328.12MFloat Cap7.73052wk Low--Dividend TTM34.91MShs Float79.749Highest--Div Yield TTM2.34%Range %4.320Lowest9.577Avg Price1Lot Size
About Prothena Company
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Company Profile
SymbolPRTA
Company NameProthena
Listing DateDec 18, 2012
ISINIE00B91XRN20
Founded2012
CEODr. Gene G. Kinney, PhD
MarketNASDAQ
Employees67
Fiscal Year Ends12-31
Address77 Sir John Rogersons Quay,Grand Canal Docklands,Block C
CityDublin
ProvinceDublin
CountryIreland
Zip Code2
Phone353-1-236-2500
Websitehttp://www.prothena.com
Company Executives
- Name
- Position
- Salary
- Dr. Gene G. Kinney, PhD
- Director, President and Chief Executive Officer
- 5.90M
- Karin L. Walker
- Chief Accounting Officer
- --
- Tran B. Nguyen
- Chief Strategy Officer and Chief Financial Officer
- 2.66M
- Michael J. Malecek
- Chief Legal Officer and Company Secretary
- --
- Chad J. Swanson
- Chief Development Officer
- 2.42M
- Brandon S. Smith
- Chief Operating Officer
- 2.81M
- Dr. Wagner M. Zago, PhD
- Chief Scientific Officer
- 2.41M
- Daniel G. Welch
- Chairman of the Board
- 192.92K
- Dr. Lars G. Ekman, M.D.,PhD
- Chairman Emeritus and Director
- 175.83K
- Shane M. Cooke
- Independent Director
- 183.33K
- Richard T. Collier
- Independent Director
- 175.83K
- Dr. William H. Dunn, Jr
- Independent Director
- 170.56K
- Dr. Dennis J. Selkoe, M.D.
- Independent Director
- 172.33K
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm